Serotonergic markers in Parkinson's disease and levodopa‐induced dyskinesias

Publisher： John Wiley & Sons Inc

E-ISSN： 1531-8257|30|6|796-804

ISSN： 0885-3185

Source： MOVEMENT DISORDERS, Vol.30, Iss.6, 2015-05, pp. : 796-804

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nicotine reduces established levodopa‐induced dyskinesias in a monkey model of Parkinson's disease

By  

MOVEMENT DISORDERS, Vol. 28, Iss. 10, 2013-09 ,pp. : 1398-1406

John Wiley & Sons Inc

Access to resources Recommend Favorite

The motor inhibition system in Parkinson's disease with levodopa‐induced dyskinesias

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 14, 2015-12 ,pp. : 1912-1920

John Wiley & Sons Inc

Access to resources Recommend Favorite

Optogenetic Inhibition of the Subthalamic Nucleus Reduces Levodopa-Induced Dyskinesias in a Rat Model of Parkinson's Disease

By  

Stereotactic and Functional Neurosurgery, Vol. 94, Iss. 1, 2016-03 ,pp. : 41-53

Karger

Access to resources Recommend Favorite

Serotonergic antidepressant drugs and L‐dopa‐induced dyskinesias in Parkinson's disease

By  

ACTA NEUROLOGICA SCANDINAVICA (ELECTRONIC), Vol. 131, Iss. 3, 2015-03 ,pp. : 191-195

John Wiley & Sons Inc

Access to resources Recommend Favorite

Coffee consumption and risk of levodopa‐induced dyskinesia in Parkinson's disease: The FRAGAMP study

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 13, 2015-11 ,pp. : 1854-1856

John Wiley & Sons Inc

Access to resources Recommend Favorite